Direxion Daily Biotech Top 5 Bull 2X ETF
TBXU
3 hedge funds and large institutions have $2.28M invested in Direxion Daily Biotech Top 5 Bull 2X ETF in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
58.65% more ownership
Funds ownership: 0% → 58.65% (+59%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$747K |
| 2 |
Goldman Sachs
New York
|
+$747K |
| 3 |
GS
GTS Securities
New York
|
+$696K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Bank of America
Charlotte,
North Carolina
| $777K | +$747K | +25,000 | New |
|
|
2
Goldman Sachs
New York
| $777K | +$747K | +25,000 | New |
|
|
GS
3
GTS Securities
New York
| $724K | +$696K | +23,310 | New |
|
TBXU Hedge Fund Activity: Q4 2025 in Review
3 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) for Q4 2025, worth a combined $2.28M.
Buyers outnumbered sellers: 3 funds opened new TBXU positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $747K.
- 3 institutional investors held Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) as of Q4 2025, up from 0 in Q3 2025.
- Funds reported $2.28M of Direxion Daily Biotech Top 5 Bull 2X ETF stock for Q4 2025.
- 3 funds opened new Direxion Daily Biotech Top 5 Bull 2X ETF positions in Q4 2025 and 0 closed out, a net change of +3 holders.
- The largest Direxion Daily Biotech Top 5 Bull 2X ETF buyer in Q4 2025 was Bank of America, an estimated $747K added.
Based on aggregated 13F filings for Q4 2025.